Geneos Wealth Management’s Vanguard Long-Term Corporate Bond ETF VCLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.44M | Buy |
32,434
+6,670
| +26% | +$500K | 0.05% | 342 |
|
|
2026
Q1 | $1.93M | Buy |
25,764
+5,657
| +28% | +$430K | 0.04% | 362 |
|
|
2025
Q4 | $1.53M | Buy |
20,107
+8,897
| +79% | +$687K | 0.04% | 401 |
|
|
2025
Q3 | $870K | Buy |
11,210
+606
| +6% | +$46.1K | 0.02% | 520 |
|
|
2025
Q2 | $805K | Buy |
10,604
+5,350
| +102% | +$395K | 0.02% | 589 |
|
|
2025
Q1 | $399K | Buy |
5,254
+55
| +1% | +$4.15K | 0.01% | 695 |
|
|
2024
Q4 | $389K | Buy |
5,199
+1,089
| +26% | +$84.7K | 0.01% | 646 |
|
|
2024
Q3 | $334K | Buy |
4,110
+1,335
| +48% | +$106K | 0.01% | 642 |
|
|
2024
Q2 | $211K | Buy |
2,775
+489
| +21% | +$37.1K | 0.01% | 694 |
|
|
2024
Q1 | $179K | Buy |
2,286
+7
| +0.3% | +$546 | 0.01% | 723 |
|
|
2023
Q4 | $183K | Buy |
2,279
+810
| +55% | +$59.6K | 0.01% | 696 |
|
|
2023
Q3 | $105K | Buy |
1,469
+9
| +0.6% | +$678 | 0.01% | 859 |
|
|
2023
Q2 | $115K | Buy |
1,460
+9
| +0.6% | +$703 | 0.01% | 841 |
|
|
2023
Q1 | $116K | Buy |
1,451
+6
| +0.4% | +$473 | 0.01% | 799 |
|
|
2022
Q4 | $109K | Buy |
1,445
+11
| +0.8% | +$827 | 0.01% | 809 |
|
|
2022
Q3 | $105K | Buy |
1,434
+421
| +42% | +$34.1K | 0.01% | 787 |
|
|
2022
Q2 | $83K | Hold |
1,013
| – | – | ﹤0.01% | 1084 |
|
|
2022
Q1 | $94K | Hold |
1,013
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q4 | $107K | Sell |
1,013
-76
| -7% | -$8.09K | ﹤0.01% | 1136 |
|
|
2021
Q3 | $115K | Hold |
1,089
| – | – | ﹤0.01% | 1111 |
|
|
2021
Q2 | $116K | Sell |
1,089
-26
| -2% | -$2.69K | ﹤0.01% | 1110 |
|
|
2021
Q1 | $114K | Buy |
1,115
+10
| +0.9% | +$1.05K | ﹤0.01% | 1245 |
|
|
2020
Q4 | $109K | Sell |
1,105
-469
| -30% | -$51K | ﹤0.01% | 1113 |
|
|
2020
Q3 | $168K | Buy |
1,574
+4
| +0.3% | +$437 | 0.01% | 742 |
|
|
2020
Q2 | $165K | Buy |
1,570
+5
| +0.3% | +$512 | 0.01% | 725 |
|
|
2020
Q1 | $151K | Buy |
1,565
+552
| +54% | +$55.9K | 0.01% | 705 |
|
|
2019
Q4 | $103K | Hold |
1,013
| – | – | 0.01% | 943 |
|
|
2019
Q3 | $102K | Buy |
1,013
+148
| +17% | +$14.7K | 0.01% | 889 |
|
|
2019
Q2 | $83K | Buy |
865
+320
| +59% | +$29.5K | 0.01% | 978 |
|
|
2019
Q1 | $49K | Hold |
545
| – | – | ﹤0.01% | 1157 |
|
|
2018
Q4 | $46K | Hold |
545
| – | – | ﹤0.01% | 1135 |
|
|
2018
Q3 | $47K | Hold |
545
| – | – | ﹤0.01% | 1198 |
|
|
2018
Q2 | $47K | Hold |
545
| – | – | ﹤0.01% | 1082 |
|
|
2018
Q1 | $49K | Hold |
545
| – | – | ﹤0.01% | 1006 |
|
|
2017
Q4 | $52K | Buy |
545
+215
| +65% | +$20.3K | ﹤0.01% | 984 |
|
|
2017
Q3 | $31K | Buy |
+330
| New | +$30.9K | ﹤0.01% | 1159 |
|
Other funds holding VCLT
MYLI
A
NMIMC
Geneos Wealth Management's VCLT Position: Q2 2026 in Review
Geneos Wealth Management increased its Vanguard Long-Term Corporate Bond ETF (VCLT) stake by 26% in Q2 2026, buying an estimated $500K and bringing the position to 32,434 shares worth $2.44M. The position accounts for 0.05% of the portfolio, ranked #342.
Geneos Wealth Management first reported a position in VCLT in Q3 2017 and has held it in 36 quarters since. 361 funds tracked by Wall St. Rank hold VCLT as of Q2 2026.
- Geneos Wealth Management held 32,434 shares of Vanguard Long-Term Corporate Bond ETF worth $2.44M as of Q2 2026.
- Geneos Wealth Management bought 6,670 Vanguard Long-Term Corporate Bond ETF shares in Q2 2026, an estimated $500K.
- Vanguard Long-Term Corporate Bond ETF made up 0.05% of Geneos Wealth Management's portfolio in Q2 2026, its #342 holding.
- Geneos Wealth Management first reported a position in Vanguard Long-Term Corporate Bond ETF in Q3 2017 and has held it in 36 quarters since.
- 361 funds tracked by Wall St. Rank held Vanguard Long-Term Corporate Bond ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.